Foundation Medicine Inc (NASDAQ:FMI) People

Foundation Medicine Inc

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David Schenkein
Other companies: Regeneron Pharmaceuticals, Inc. (Director · Since at least Sep 8, 2023); Prime Medicine, Inc. (Board Member · Since at least Oct 19, 2022); Denali Therapeutics Inc. (Director · Since at least Dec 7, 2017); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Jun 20, 2024 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Jun 18, 2020 · Past); Foghorn Therapeutics Inc. (General Partner, Co-leader, Agios · Until Apr 13, 2026 · Past)
Director · Sep 24, 2013 – Jun 16, 2016 · Past
Sandra J. Horning
Other companies: Revolution Medicines, Inc. (Director · Since at least Nov 9, 2023); Olema Pharmaceuticals, Inc. (Director · Since at least Nov 18, 2020); Moderna, Inc. (Director · Since at least Apr 29, 2020); Gilead Sciences, Inc. (Director · Since at least Jan 28, 2020); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past)
Director · Apr 7, 2015 – Apr 7, 2015 · Past
Brook H Byers
Other companies: CareDx, Inc. (Director · Jul 16, 2014 – Apr 1, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – May 20, 2014 · Past); Pacific Biosciences of California, Inc. (Director · Oct 26, 2010 – May 17, 2016 · Past); Genomic Health Inc (Director · May 25, 2006 – Apr 1, 2011 · Past)
Director · Sep 24, 2013 – Apr 7, 2015 · Past
Evan Jones
Other companies: Veracyte, Inc. (Board Member · Since at least Oct 29, 2013); CapForce Inc. (Director · May 4, 2015 – May 17, 2021 · Past); CAS Medical Systems Inc (Director · Jun 20, 2012 – Jun 24, 2013 · Past); Standard BioTools Inc. (Director · Dec 12, 2011 – Jul 31, 2017 · Past)
Director · Sep 24, 2013 – Jul 31, 2018 · Past
Troy Cox
Other companies: MapLight Therapeutics, Inc. (Chair of the Nominating and Corporate Governance Committee · Since at least Jun 23, 2026); Sophia Genetics SA (Board Member and Lead Independent Director · Since at least Mar 18, 2026); Standard BioTools Inc. (Director · Since at least Jan 5, 2024); Zymeworks Inc. (Director · Jun 3, 2019 – Dec 10, 2024 · Past)
President and CEO, Director · Feb 6, 2017 – Jul 31, 2018 · Past
Jason Ryan
Other companies: GeneDx Holdings Corp. (Director · Since at least Jul 22, 2021); Singular Genomics Systems Inc (Director · May 26, 2021 – Feb 21, 2025 · Past); Dianthus Therapeutics, Inc. (See Remarks · Jan 1, 2019 – Feb 10, 2020 · Past)
Chief Financial Officer · Sep 24, 2013 – Jul 31, 2018 · Past
Krishna Yeshwant
Other companies: Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Verve Therapeutics Inc (Director · Since at least Jun 16, 2021); EQRx Inc (Director · Dec 17, 2021 – Nov 9, 2023 · Past)
Director · Jun 16, 2016 – Jul 31, 2018 · Past
Mark J Levin
Other companies: Fulcrum Therapeutics, Inc. (Director · Jul 17, 2019 – Nov 10, 2021 · Past); Voyager Therapeutics, Inc. (Director · Nov 10, 2015 – Jun 3, 2021 · Past); Eleven Biotherapeutics Inc (Director · Feb 5, 2014 – Mar 20, 2014 · Past)
Director · Sep 24, 2013 – May 12, 2014 · Past
David Daly
Other companies: NeoGenomics, Inc. (Director · Nov 10, 2021 – Jun 10, 2022 · Past); Singular Genomics Systems Inc (President and Chief Operating · May 26, 2021 – Mar 4, 2022 · Past)
Chief Commercial Officer · Dec 2, 2014 – Aug 9, 2017 · Past
Michael Varney
Other companies: Erasca, Inc. (Chair of R&D, SAB Member and Board Director · Since at least Jul 15, 2021); Pardes Biosciences Inc (Director · Dec 23, 2021 – Aug 31, 2023 · Past)
Director · Apr 7, 2015 – Apr 7, 2015 · Past
Steven J Kafka
Other companies: Da32 Life Science Tech Acquisition Corp (Chief Executive Officer, Director · Jul 27, 2021 – Jul 27, 2021 · Past)
President & COO · Sep 24, 2013 – Feb 13, 2018 · Past
Konstantin FiedlerChief Operating Officer · Feb 16, 2018 – Jul 31, 2018 · Past
Michael J DohertyHead of Product Development · Jun 20, 2017 – Jul 31, 2018 · Past